Get the Stockscreener App
12.62
3.59%
-0.47
After Hours:
12.66
0.04
+0.32%
Rxsight Inc stock is traded at $12.62, with a volume of 587.32K.
It is down -3.59% in the last 24 hours and up +26.07% over the past month.
RxSight Inc is a commercial-stage medical technology company dedicated towards improving the vision of patients following cataract surgery. It offers intraocular lens technology that enables doctors to customize and optimize visual acuity for patients after cataract surgery. The company operates and manages its business in one reportable segment, the research and development, manufacture and sale of light adjustable lenses and related capital equipment.
See More
Previous Close:
$13.09
Open:
$13
24h Volume:
587.32K
Relative Volume:
0.76
Market Cap:
$518.89M
Revenue:
$128.29M
Net Income/Loss:
$-30.69M
P/E Ratio:
-15.39
EPS:
-0.82
Net Cash Flow:
$-27.17M
1W Performance:
-0.08%
1M Performance:
+26.07%
6M Performance:
-11.56%
1Y Performance:
-64.84%
1-Day Range:
$12.60
$13.00
1-Week Range:
$11.84
$13.22
52-Week Range:
$6.32
$39.37
Rxsight Inc Stock (RXST) Company Profile
Name
Rxsight Inc
Sector
Industry
Phone
949-521-7822
Address
100 COLUMBIA STREET, ALISO VIEJO
Compare RXST with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
RXST
Rxsight Inc
|
12.62 | 538.22M | 128.29M | -30.69M | -27.17M | -0.82 |
|
ABT
Abbott Laboratories
|
125.46 | 214.37B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
92.58 | 136.01B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
354.09 | 134.98B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
99.87 | 127.88B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
83.08 | 48.88B | 5.88B | 1.34B | 799.60M | 2.3489 |
Rxsight Inc Stock (RXST) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-15-25 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jul-10-25 | Downgrade | Jefferies | Buy → Hold |
| Jul-09-25 | Downgrade | BTIG Research | Buy → Neutral |
| Jul-09-25 | Downgrade | Oppenheimer | Outperform → Perform |
| Jul-09-25 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| May-19-25 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Apr-15-25 | Initiated | Piper Sandler | Neutral |
| Apr-09-25 | Downgrade | UBS | Buy → Neutral |
| Apr-04-25 | Downgrade | JP Morgan | Overweight → Underweight |
| Apr-03-25 | Downgrade | BofA Securities | Buy → Underperform |
| Dec-20-24 | Downgrade | Stifel | Buy → Hold |
| Dec-11-24 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Dec-06-24 | Initiated | UBS | Buy |
| Oct-29-24 | Initiated | Jefferies | Buy |
| Aug-20-24 | Reiterated | Needham | Buy |
| Aug-06-24 | Reiterated | Needham | Buy |
| May-07-24 | Reiterated | BTIG Research | Buy |
| Dec-13-23 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Dec-12-23 | Initiated | Stifel | Buy |
| Dec-04-23 | Initiated | Morgan Stanley | Overweight |
| Apr-13-23 | Initiated | Oppenheimer | Outperform |
| Dec-12-22 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Apr-08-22 | Initiated | Needham | Buy |
View All
Rxsight Inc Stock (RXST) Latest News
RxSight, Inc.'s (NASDAQ:RXST) 28% Price Boost Is Out Of Tune With Revenues - simplywall.st
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against RxSight, Inc. (RXST) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
Divisadero Street Capital Management LP Has $2.85 Million Stock Position in RxSight, Inc. $RXST - MarketBeat
How Does Aditya Birla Capital Limited Compare to SP500 Over the Last 3 YearsChart Pattern Recognition & Free High Yield Portfolio Picks - earlytimes.in
What Makes Mason Infratech Limited a Strong Contender in YEARInstitutional Holding Changes & Minimal Investment Portfolio - earlytimes.in
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against RxSight, Inc. (RXST) And Encourages Stockholders to Reach Out - ACCESS Newswire
RxSight, Inc. (NASDAQ:RXST) Given Average Rating of "Reduce" by Brokerages - MarketBeat
RxSight, Inc. $RXST Shares Purchased by Brown Capital Management LLC - MarketBeat
Bronstein, Gewirtz & Grossman, LLC Is Investigating RxSight, Inc. (RXST) And Encourages Stockholders to Connect - ACCESS Newswire
Why RxSight Inc. stock could benefit from AI revolution2025 Market Overview & Weekly Market Pulse Updates - Newser
RxSight price target raised to $10 from $9 at Morgan Stanley - MSN
How RxSight Inc. stock benefits from global expansion2025 Market Overview & Safe Entry Point Identification - Newser
Morgan Stanley Maintains RxSight (RXST) Equal-Weight Recommendation - Nasdaq
RxSight, Inc. (RXST) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
RxSight (RXST) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
RxSight (RXST) Sees Analyst Rating Update from Morgan Stanley | - GuruFocus
RXST ALERT: Levi & Korsinsky Files Securities Fraud Class Action - The National Law Review
Investors SueWallSt as RxSight, Inc. Faces Securities Fraud Allegations - The National Law Review
RXST LAWSUIT ALERT: Levi & Korsinsky Notifies RxSight, Inc. InvestorsLead Plaintiff Deadline September 22, 2025 - The National Law Review
Grandeur Peak Global Advisors LLC Acquires 94,871 Shares of RxSight, Inc. $RXST - MarketBeat
Investors in RxSight, Inc. (RXST): Protect Your RightsContact Levi & Korsinsky Before September 22, 2025 - The National Law Review
RA CAPITAL MANAGEMENT, L.P.'s RxSight Inc(RXST) Holding History - GuruFocus
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against RxSight, Inc. (RXST) and Encourages Stockholders to Learn More About the Investigation - ACCESS Newswire
What Analysts Say Is Shifting the Story for RxSight Shares - Yahoo Finance
Ensign Peak Advisors Inc Decreases Stock Position in RxSight, Inc. $RXST - MarketBeat
Atika Capital Management LLC Sells 158,366 Shares of RxSight, Inc. $RXST - MarketBeat
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against RxSight, Inc. (RXST) and Encourages Shareholders to Learn More About the Investigation - ACCESS Newswire
RxSight, Inc. (NASDAQ:RXST) institutional owners may be pleased with recent gains after 77% loss over the past year - simplywall.st
RxSight, Inc. (RXST) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
SG Americas Securities LLC Purchases 30,333 Shares of RxSight, Inc. $RXST - MarketBeat
AXQ Capital LP Invests $405,000 in RxSight, Inc. $RXST - MarketBeat
What analysts say about RxSight Inc stockVolume Analysis Techniques & Hedge Fund-Style Analysis Now Free - earlytimes.in
Bronstein, Gewirtz & Grossman, LLC Encourages RxSight, Inc. (RXST) Shareholders to Inquire about Securities Investigation - ACCESS Newswire
76,728 Shares in RxSight, Inc. $RXST Bought by Dynamic Technology Lab Private Ltd - MarketBeat
Artisan Partners Limited Partnership Grows Position in RxSight, Inc. $RXST - MarketBeat
Midday Stock Roundup: RxSight up 14% - Orange County Business Journal
Will RxSight Inc. stock attract ESG investors2025 Performance Recap & Advanced Swing Trade Entry Plans - newser.com
RxSight, Inc. to Present at the Piper Sandler Healthcare Conference - The Manila Times
What risks investors should watch in RxSight Inc. stockTrade Volume Summary & Detailed Earnings Play Strategies - newser.com
Bronstein, Gewirtz & Grossman, LLC Is Investigating RxSight, Inc. (RXST) And Encourages Shareholders to Connect - ACCESS Newswire
Is RxSight Inc. stock a defensive play in 2025Portfolio Update Report & Long-Term Safe Investment Plans - newser.com
RxSight (Nasdaq: RXST) sets Dec. 3 talk at Piper Sandler 37th Healthcare Conference - Stock Titan
Combining price and volume data for RxSight Inc.Rate Hike & Risk Managed Investment Entry Signals - newser.com
Can RxSight Inc. stock continue upward trend2025 Top Gainers & High Accuracy Buy Signal Tips - newser.com
Rxsight Inc Stock (RXST) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.52%
0.28%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):